| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.26▲ | 1.26▲ | 1.26▲ | 1.27▼ | 1.37▼ |
| MA10 | 1.26▲ | 1.28▼ | 1.29▼ | 1.35▼ | 1.40▼ |
| MA20 | 1.30▼ | 1.35▼ | 1.37▼ | 1.42▼ | 1.42▼ |
| MA50 | 1.44▼ | 1.50▼ | 1.49▼ | 1.42▼ | 1.33▼ |
| MA100 | 1.48▼ | 1.44▼ | 1.43▼ | 1.43▼ | 1.78▼ |
| MA200 | 1.42▼ | 1.44▼ | 1.44▼ | 1.40▼ | 2.72▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | -0.004▼ | -0.009▼ | -0.027▼ | -0.018▼ |
| RSI | 34.623▼ | 31.880▼ | 31.702▼ | 37.947▼ | 44.599▼ |
| STOCH | 40.179 | 12.412▼ | 10.360▼ | 4.232▼ | 19.628▼ |
| WILL %R | -61.111 | -72.000 | -85.417▼ | -90.289▼ | -90.289▼ |
| CCI | -5.117 | -52.960 | -65.996 | -94.149 | -178.312▼ |
|
Wednesday, July 22, 2026 12:11 AM
Merck (NYSE:MRK) is in focus after it reported a clinical readout for an investigational oral HIV regimen, placing the company within current Bluechip Stocks coverage.
|
|
Monday, July 20, 2026 08:35 PM
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Merck (NYSE:MRK) and the rest ...
|
|
Sunday, July 19, 2026 06:06 AM
Merck (NYSE:MRK) received FDA approval for Lipfendra (enlicitide), the first oral PCSK9 cholesterol-lowering drug. Lipfendra introduces an oral option for patients who have so far relied on injectable ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/07/26 | 1.23 | 1.3082 | 1.2216 | 1.27 | 14,250 |
| 22/07/26 | 1.26 | 1.285 | 1.24 | 1.24 | 42,583 |
| 21/07/26 | 1.28 | 1.32 | 1.27 | 1.27 | 26,162 |
| 20/07/26 | 1.29 | 1.32 | 1.28 | 1.28 | 58,339 |
| 17/07/26 | 1.31 | 1.3799 | 1.30 | 1.31 | 30,822 |
| 16/07/26 | 1.40 | 1.4154 | 1.31 | 1.34 | 69,075 |
| 15/07/26 | 1.44 | 1.4401 | 1.4002 | 1.41 | 19,204 |
| 14/07/26 | 1.48 | 1.48 | 1.44 | 1.44 | 21,460 |
| 13/07/26 | 1.51 | 1.53 | 1.45 | 1.46 | 34,634 |
| 10/07/26 | 1.59 | 1.59 | 1.51 | 1.51 | 70,894 |
|
|
||||
|
|
||||
|
|